C3 Glomerulopathy Clinical Trials in Prague
2 recruitingPrague, Czechia
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
C3 Glomerulopathy (C3G)
eleva GmbH39 enrolled16 locationsNCT07483827
Recruiting
Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
C3 GlomerulopathyImmune-complex-membranoproliferative Glomerulonephritis
Novartis Pharmaceuticals225 enrolled50 locationsNCT03955445